Bloggers

Lisa Banket
Cofounding Partner/Publisher
VIEW MY COMPLETE PROFILE
Taren Grom
Cofounding Partner/Editor-in-Chief
VIEW MY COMPLETE PROFILE
Heather Hummel
Project Coordinator
VIEW MY COMPLETE PROFILE
Dan Limbach
Producer, Webcast Network
VIEW MY COMPLETE PROFILE
Denise Myshko
Managing Editor
VIEW MY COMPLETE PROFILE
Kim Ribbink
Features Editor
VIEW MY COMPLETE PROFILE
Robin Robinson
Senior Editor
VIEW MY COMPLETE PROFILE
Marah Walsh
Cofounding Partner/New Business Development
VIEW MY COMPLETE PROFILE

PharmaVOICE Editors' Blog

Showing posts with label drug discovery. Show all posts
Showing posts with label drug discovery. Show all posts

Thursday, May 8, 2014

Featured White Paper - Anticipating Success: Meeting the Inherent Challenges of Complex Drug Substances

PharmaVOICE Webcast Network

Throughout May, we are featuring an informative white paper provided by Vetter. The paper discusses the scientific and technical challenges that can crop up from the discovery phase to the commercial launch of a complex substance.

These challenges may be overcome with a systematic approach, which is consistent and repeatable.

You’ll learn about:
• The rise of injectables
• Patient-friendly delivery systems
• Optimizing yields
• Reducing overfilling
• Life cycle management
• 8 important questions that help avoid roadblocks

Download this free white paper now at http://bit.ly/0414vetterwp

PharmaVOICE Webcast Network

Friday, February 22, 2013

Computing Tools that Power Breakthroughs in Drug Discovery

I found this compelling 6-minute video on Computer Aided Drug Discovery. This technology will have a major effect on the drug discovery process.


Computers can crunch drug simulations and drive innovation faster than we've ever seen in our history.

The National Biomedical Computation Resource is developing tools that will drive drug discovery to new heights. This can result in faster generation of new molecular entities, and identify more candidates for drug development, which means fatter product pipelines, and possibly better outcomes.